Atossa Therapeutics, Inc.
ATOS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001488039
No open-market purchases or sales by Atossa Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $2.60M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Atossa Therapeutics, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 77 | 1 | 86 | +10 |
| Shares | 26.2M | 9.20M | 27.3M | +10.3M (+60.6%) |
| Value | $31.2M | $10.9M | $41.6M | +$21.3M (+105.5%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Atossa Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 9,667,615 | $14.7M | 0.00% |
| Susquehanna International Group, LLP | 71,772 | $109.1K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 69,402 | $105.5K | 0.00% |
| Manufacturers Life Insurance Company, The | 49,113 | $74.7K | 0.00% |
| Two Sigma Securities, LLC | 24,196 | $36.8K | 0.00% |
| ProShare Advisors LLC | 23,902 | $36.3K | 0.00% |
| Intech Investment Management LLC | 19,395 | $29.5K | 0.00% |
| HSBC Holdings PLC | 16,220 | $25.1K | 0.00% |
| DnB Asset Management AS | 15,400 | $23.4K | 0.00% |
| Acadian Asset Management LLC | 14,586 | $22.0K | 0.00% |
| Neuberger Berman Group LLC | 12,286 | $18.7K | 0.00% |
| CWM, LLC | 394 | $1.00K | 0.00% |
| Signaturefd, LLC | 400 | $608 | 0.00% |
| Nisa Investment Advisors, LLC | 380 | $578 | 0.00% |
| Sterling Capital Management LLC | 355 | $540 | 0.00% |
| Larson Financial Group LLC | 100 | $152 | 0.00% |
| Capital Performance Advisors LLP | 25 | $38 | 0.00% |
Sold out (7)
Institutions that held Atossa Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Mariner, LLC | 105,910 | $126.0K |
| Edmond de Rothschild Holding S.A. | 50,000 | $59.5K |
| Group One Trading, L.P. | 24,198 | $28.8K |
| Ground Swell Capital, LLC | 14,466 | $17.2K |
| Alpine Global Management, LLC | 12,168 | $14.5K |
| Millennium Management LLC | 10,662 | $12.7K |
| Unique Wealth Strategies, LLC | 166 | $299 |
Not filed for Q3 2024 yet (1)
Institutions that held Atossa Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 9,197,040 | $10.9M |